Viewing Study NCT04887259

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2026-01-22 @ 4:14 PM
Study NCT ID: NCT04887259
Status: TERMINATED
Last Update Posted: 2025-01-27
First Post: 2021-05-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
Sponsor: Lava Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None Multiple Myeloma View
None Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CLL View
None Phase 1 dose escalation View
None Phase 1 safety View
None Open label View
None MM View
None AML View
None relapsed View
None refractory View